UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Opto-electronic memristors: Prospects and challenges in neuromorphic computing

Applied physics letters, 2020-12, Vol.117 (23)

2020

Volltextzugriff (PDF)

Single neuromorphic memristor closely emulates multiple synaptic mechanisms for energy efficient neural networks

Nature communications, 2024-08, Vol.15 (1), p.6898-13, Article 6898

2024

Volltextzugriff (PDF)

Analog Nanoscale Electro-Optical Synapses for Neuromorphic Computing Applications

ACS nano, 2021-09, Vol.15 (9), p.14776-14785

2021

Volltextzugriff (PDF)

Multiscale Modeling of Metal-Oxide-Metal Conductive Bridging Random-Access Memory Cells: From Ab Initio to Finite-Element Calculations

Physical review applied, 2023-02, Vol.19 (2), Article 024058

2023

Volltextzugriff (PDF)

Light-Controlled Switching in Electro-Optical Memristors

2022 Conference on Lasers and Electro-Optics (CLEO), 2022, p.1-2

2022

Volltextzugriff (PDF)

Integrated Photonic-Electronic Memristors

2022 Conference on Lasers and Electro-Optics (CLEO), 2022, p.1-2

2022

Volltextzugriff (PDF)

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

The Lancet (British edition), 2014-12, Vol.384 (9960), p.2111-2122

2014

Volltextzugriff (PDF)

Locus Coeruleus Activity Mediates Hyperresponsiveness in Posttraumatic Stress Disorder

Biological psychiatry (1969), 2018-02, Vol.83 (3), p.254-262

2018

Volltextzugriff (PDF)

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

The Lancet (British edition), 2019-10, Vol.394 (10205), p.1243-1253

2019

Volltextzugriff (PDF)

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

The Lancet (British edition), 2018-09, Vol.392 (10150), p.849-856

2018

Volltextzugriff (PDF)

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

The New England journal of medicine, 2010-12, Vol.363 (24), p.2310-2319

2010

Volltextzugriff (PDF)

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

The Lancet (British edition), 2018-09, Vol.392 (10149), p.737-746

2018

Volltextzugriff (PDF)

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial

The Lancet (British edition), 2023-11, Vol.402 (10416), p.1979-1990

2023

Volltextzugriff (PDF)

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II

PloS one, 2019-01, Vol.14 (1), p.e0210821-e0210821

2019

Volltextzugriff (PDF)

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI

JACC. Cardiovascular interventions, 2021-03, Vol.14 (6), p.639-648

2021

Volltextzugriff (PDF)

TCT-167 Percutaneous Coronary Intervention With Ultrathin-Strut Biodegradable Versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized Trials

Journal of the American College of Cardiology, 2022-09, Vol.80 (12), p.B67

2022

Volltextzugriff (PDF)

Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial

Catheterization and cardiovascular interventions, 2023-03, Vol.101 (4), p.687-700

2023

Volltextzugriff (PDF)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial

Journal of the American Heart Association, 2016-03, Vol.5 (3), p.e003255-n/a

2016

Volltextzugriff (PDF)

Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials

The American heart journal, 2023-09, Vol.263, p.73-84

2023

Volltextzugriff (PDF)

Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

Journal of the American Heart Association, 2019-11, Vol.8 (22), p.e013607-e013607

2019

Volltextzugriff (PDF)

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial

JACC. Cardiovascular interventions, 2021-08, Vol.14 (16), p.1789-1798

2021

Volltextzugriff (PDF)

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

Clinical cardiology (Mahwah, N.J.), 2018-05, Vol.41 (5), p.569-575

2018

Volltextzugriff (PDF)

Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial

Clinical research in cardiology, 2024-07, Vol.113 (7), p.959-966

2024

Volltextzugriff (PDF)

Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial

JACC. Cardiovascular interventions, 2020-10, Vol.13 (19), p.2314-2316

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)
Tagungsberichte
(2)

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Opto-electronic memristors: Prospects and challenges in neuromorphic computing

Single neuromorphic memristor closely emulates multiple synaptic mechanisms for energy efficient neural networks

Analog Nanoscale Electro-Optical Synapses for Neuromorphic Computing Applications

Multiscale Modeling of Metal-Oxide-Metal Conductive Bridging Random-Access Memory Cells: From Ab Initio to Finite-Element Calculations

Light-Controlled Switching in Electro-Optical Memristors

Integrated Photonic-Electronic Memristors

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

Locus Coeruleus Activity Mediates Hyperresponsiveness in Posttraumatic Stress Disorder

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI

TCT-167 Percutaneous Coronary Intervention With Ultrathin-Strut Biodegradable Versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized Trials

Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial

Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial

Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials

Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial

Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial

Suchergebnisse filtern